Worsening of motor symptoms and gynecomastia during spironolactone treatment in a patient with Parkinson's disease and congestive heart failure [10]

Movement Disorders

Volumn 22, Issue 11, 2007, Pages 1678-1679

  Teive, Hélio A G ^a   Munhoz, Renato P ^a   Werneck, Lineu C ^a  

^a FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTIPARKINSON AGENT; BENSERAZIDE; DIGOXIN; ENTACAPONE; FUROSEMIDE; LEVODOPA BENZERAZIDE; SPIRONOLACTONE; UNCLASSIFIED DRUG;

AGED; CASE REPORT; CONGESTIVE HEART FAILURE; DISEASE EXACERBATION; DRUG RESPONSE; DRUG WITHDRAWAL; GYNECOMASTIA; HUMAN; LABORATORY TEST; LETTER; MALE; MOTOR DYSFUNCTION; MOTOR PERFORMANCE; NEUROLOGIC EXAMINATION; PARKINSON DISEASE; PRIORITY JOURNAL; SYMPTOM;

AGED; ALDOSTERONE ANTAGONISTS; GYNECOMASTIA; HEART FAILURE; HUMANS; MALE; MOVEMENT DISORDERS; PARKINSON DISEASE; SPIRONOLACTONE;

EID: 34748910837     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.21579     Document Type: Letter

References (7)

1. Futterman LG, Lemberg L. The resurrection of spironolactone on its golden anniversary. Am J Crit Care 2004;13:162-165.
2. Corvol P, Michaud A, Menard J, Freifeld M, Mahoudeau J. Anti-androgenic effect of spirolactones: mechanism of action. Endocrinology 1975;97:52-58.
3. Spritzer PM, Lisboa KO, Mattiello S, Lhullier F. Spironolactone as a single agent for long-term therapy of hirsute patients. Clin Endocrinol 2001;54:699-700.
4. Opalinska-Ciszek E, Niemczyk S, Matuszkiewicz-Rowinska. Prolactin (PRL), thyrotropin (TSH), free thyroid hormones (fT4), (fT3) and testosterone (TTE) level in men with chronic heart failure. Pol Arch Med Wewn 2005;113:320-325
5. Agnoli A, Baldassarre M, Ruggieri S, Falaschi P, Urso RD, Rocco A. Prolactin response as an index of dopaminergic receptor function in Parkinson's disease. Correlation with clinical findings and therapeutic response. J Neural Transm 1981;51:123-134.
6. Okun MS, McDonald WM, DeLong MR. Refractory nonmotor symptoms in male patients with Parkinson disease due to testosterone deficiency: a common unrecognized comorbidity. Arch Neurol 2002;59:807-811.
7. Ready RE, Friedman J, Grace J, Fernandez H. Testosterone deficiency and apathy in Parkinson's disease: a pilot study. J Neurol Neurosurg Psychiatry 2004;75:1323-1326.